Diclofenac does not modify methadone bioavailability in cancer patients [1]

Journal of Pain and Symptom Management

Volumn 17, Issue 4, 1999, Pages 227-

  Bianchi, M ^a   Clavenna, A ^a   Groff, L ^a   Zecca, E ^a   Ripamonti, C ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; METHADONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; AREA UNDER THE CURVE; CANCER PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG SOLUBILITY; FEMALE; HUMAN; LETTER; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0032948938     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(98)00151-1     Document Type: Letter

References (10)